Core Insights - Astellas Pharma US, Inc. has launched "Cooler Moments" to educate and empower women experiencing moderate to severe menopausal hot flashes and night sweats, also known as vasomotor symptoms (VMS) [2][4] - The initiative features Dr. Jen Ashton, a women's health expert, who will host a video series to debunk menopause myths and encourage women to discuss treatment options with their healthcare providers [2][3] - VEOZAH, a hormone-free treatment for VMS, is highlighted as a key option for women who cannot or choose not to take hormone therapy [2][4] Company Overview - Astellas Pharma is a global pharmaceutical company operating in over 70 countries, focusing on creating new drugs for diseases with high unmet medical needs [5] - The company aims to elevate conversations around menopause and VMS, ensuring women are informed and empowered to seek appropriate support [2][5] Product Information - VEOZAH (fezolinetant) is a neurokinin 3 receptor antagonist approved in the U.S. for treating moderate to severe VMS due to menopause [3][4] - Nearly half of women undergoing menopause in the U.S. may experience moderate to severe VMS, which can significantly disrupt daily life [4][5] - VEOZAH works by modulating neuronal activity in the hypothalamus to reduce the frequency and severity of VMS [4][5]
Astellas and Dr. Jen Ashton launch "Cooler Moments" to Spotlight Menopausal Hot Flashes and Empower Women to Advocate for Themselves